US Stock Futures Fall as Treasury Yields Surge Ahead of Trump-Xi Summit 
Japanese Yen Rebounds as Trump Flags Currency Weakness 
Gold Prices Fall as Treasury Yields Rise on Fed Rate Hike Bets 
Australia Unemployment Hits Five-Year High Despite Strong Jobs Growth 
Gold Holds Near $4,275 as Rising Treasury Yields Fuel Fed Rate Hike Bets 
Asian Currencies Mixed as Dollar Holds Near Two-Month High 
Dollar Falls as Oil Eases, Yen Jumps on Intervention Signals 
Oil Prices Jump 3% as Houthi Attack Revives Supply Fears 
Soybean Futures Slip as Traders Await Trump-Xi Trade Signals 
Mexico-US Trade Talks Delayed to October as Tariff Negotiations Continue 
RBI Uses $10 Billion Currency Swaps to Drain Excess Rupee Liquidity 
Asian Stocks Fall as Surging Bond Yields Rattle Markets 
China Agrees to Buy 20 Million Tons of U.S. Coal 
U.S. Dollar Hits Two-Month High as Oil, Treasury Yields Surge 
Japanese Bank Stocks Surge as Bond Yields Fuel Rate Hike Bets 
European Stocks Fall as Bond Yields and Geopolitical Risks Weigh 
Add as a preferred source on Google
Ireland’s economic growth is expected to slow in 2024 as global risks mount, posing a significant challenge to its multinational-driven economy, the country's central bank warned. The bank revised its forecast for modified domestic demand (MDD) to 2.7% from 3.1%, citing uncertainty affecting consumption, exports, and investment.
A key concern is Ireland’s heavy reliance on U.S. multinational corporations, which contribute significantly to employment, tax revenue, and exports. U.S. President Donald Trump’s recent criticism of Ireland’s trade surplus and low corporate tax rate has intensified fears of economic disruption. His proposed 25% tariff on pharmaceutical imports and potential tax policy shifts could heavily impact Ireland’s economy, especially if companies are incentivized to relocate production and profits back to the U.S.
The foreign multinational sector, predominantly U.S.-owned, employs 11% of Ireland’s workforce and accounts for a major share of corporate tax revenue, which makes up 26% of total tax collected. The central bank warned that policy changes in Washington could cause a fiscal shock by significantly reducing corporate tax inflows.
Despite the risks, Ireland’s pharmaceutical exports to the U.S. have surged, growing by 68% year-on-year in January, driven partly by increased demand for weight-loss drugs. While some of this may be linked to stockpiling ahead of potential tariffs, absent any trade barriers, it could provide an unexpected boost to exports.
The central bank emphasized Ireland’s vulnerability to decisions made by a few multinational firms but noted possible upsides if export trends continue. As uncertainty looms, policymakers must navigate these risks to safeguard economic stability.
